Streetbeat News

Assets

CLOV

Clover Health Investments (NYSE:CLOV) has seen a 6.6% increase in its short percent of float since the last report, with 29.52 million shares sold short, representing 7.43% of available shares. This indicates a bearish market sentiment, although it's not a definitive predictor of stock price movement. Clover Health's short interest is higher than its peer group average of 3.32%.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 4:15 pm

SNY

Private equity firms, including CD&R, are considering leveraged financing of approximately €7.5 billion ($8.16 billion) for the acquisition of Sanofi's consumer health division. This potential deal could rank as one of the largest leveraged buyouts in recent history. The financing is expected to involve both banks and direct lenders.

Portfolio Pulse from Benzinga Newsdesk

March 15, 2024 | 4:03 pm

CMC

Commercial Metals (NYSE:CMC) has significantly outperformed the market with an average annual return of 26.97% over the past 5 years, turning a $100 investment into $328.99 today. The company's market capitalization stands at $6.20 billion.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 4:00 pm

CAH

Over the past 5 years, Cardinal Health (NYSE:CAH) has outperformed the market with an annualized return of 16.9%, growing a $100 investment to $220.87. The company's market capitalization stands at $26.58 billion.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 4:00 pm

AMZN

Amazon.com (NASDAQ:AMZN) is analyzed in comparison to its competitors in the Broadline Retail industry, focusing on financial metrics and market position. Despite high PE, PB, and PS ratios suggesting overvaluation, Amazon's strong EBITDA and gross profit indicate robust operational performance. However, its lower ROE and revenue growth compared to the industry average raise concerns about its efficiency and sales environment.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 4:00 pm

MCD

McDonald's Corporation (NYSE:MCD) experienced a global technology system outage affecting multiple locations, which has been identified and corrected. The outage, caused by a third-party provider during a configuration change, impacted operations including order-taking and food service in regions such as Japan, Australia, New Zealand, and Europe. McDonald's EVP, Brian Rice, emphasized the importance of technology reliability and stated the issue was not due to a cybersecurity event. Shares of McDonald's traded lower by 0.60% to $279.96 following the news.

Portfolio Pulse from Nabaparna Bhattacharya

March 15, 2024 | 3:56 pm

ROKU

Deep-pocketed investors have shown a divided sentiment towards Roku (NASDAQ:ROKU), with options trading activity indicating both bullish and bearish positions. Benzinga's tracking revealed 12 significant options activities, with a price target range between $60.0 and $115.0. The trading volume and open interest suggest heightened interest in ROKU's options. Currently, ROKU's stock is slightly down by -0.25%, trading at $64.5, and might be considered oversold based on RSI readings. The anticipated earnings release is in 40 days, adding to the stock's watchfulness.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 3:31 pm

MSTR

MicroStrategy Incorporated (NASDAQ:MSTR) announced the pricing of its $525 million offering of 0.875% convertible senior notes due 2031, with an option to purchase up to an additional $78.75 million. The offering, intended for acquiring more Bitcoin and general corporate purposes, was upsized from $500 million. As of March 10, MicroStrategy held approximately 205,000 bitcoins. The company's stock has an average 1-year price target of $1,387.00, indicating a potential downside, with shares currently trading up 0.49% at $1,685.09.

Portfolio Pulse from Erica Kollmann

March 15, 2024 | 3:30 pm

EXPE

Expedia Group (NASDAQ:EXPE) has delivered an average annual return of 20.09% over the past 15 years, turning a $100 investment into $1,705.08 today. The company's market capitalization stands at $18.42 billion.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 3:30 pm

NVO

Over the past 10 years, Novo Nordisk (NYSE:NVO) has produced an average annual return of 19.39%, outperforming the market by 8.87%. A $100 investment in NVO a decade ago would now be worth $585.05. The company's current market capitalization stands at $598.14 billion.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 3:30 pm